Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired by private equity firm
|
| gptkbp:awards |
Various industry awards
|
| gptkbp:CEO |
gptkb:Dr._Klaus_W._W._Schaefer
|
| gptkbp:clinicalTrials |
Ongoing clinical trials
|
| gptkbp:collaborations |
Joint ventures
Collaborative research projects Partnerships with biotech firms |
| gptkbp:communityEngagement |
Research funding
Health education programs Local community support |
| gptkbp:employees |
Approximately 1,500
|
| gptkbp:financialPerformance |
Revenue growth
Publicly traded Profitability Market capitalization |
| gptkbp:focusArea |
Autoimmune diseases
Infectious diseases Chronic diseases Rare diseases |
| gptkbp:founded |
1946
|
| gptkbp:futurePlans |
Investment in R&D
Expansion into new markets Product line expansion |
| gptkbp:headquarters |
gptkb:Dreieich,_Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Biotest AG
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:innovation |
Technology advancements
New product development Focus_on_R&D |
| gptkbp:internationalCooperation |
Manufacturing facilities
Research centers Sales offices |
| gptkbp:market |
Global presence
|
| gptkbp:partnerships |
Various academic institutions
Healthcare_organizations |
| gptkbp:products |
gptkb:Immunoglobulins
Coagulation factors Albumin Plasma products |
| gptkbp:regulatoryCompliance |
gptkb:FDA
gptkb:European_Medicines_Agency |
| gptkbp:researchFocus |
Immunology
Hematology |
| gptkbp:stockExchange |
gptkb:Frankfurt_Stock_Exchange
|
| gptkbp:stockSymbol |
BIO
|
| gptkbp:subsidiary |
Biotest Pharma
Biotest USA Biotest_AG_(Switzerland) |
| gptkbp:sustainabilityInitiatives |
Social responsibility
Environmental responsibility Economic responsibility |
| gptkbp:website |
www.biotest.com
|